Searched for
PFIZER EARNINGS REPORT
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...- Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
- US stock market today: Why is Nasdaq crashing big today? Dow and S&P 500 slip as Nasdaq plunges over 300 points - Nvidia, AMD, Intel lead tech lossesUS stock market today: Nasdaq crashing big today as Dow Jones and S&P 500 also slip. The US stock market today shows a sharp shift. The Nas...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- Buy Pfizer, target price Rs 5314: ICICI SecuritiesPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20591.05 Crore) operating in Pharmaceuticals ...
- Market Movers: Pfizer soars on likely Covid vaccine nod; TCS sinks on profit bookingShares of Tata Motors jumped nearly 6 per cent after arm Jaguar Land Rover said that it is likely to report significant free cash flow in t...
- ‘Pharma firms in 16 nations evading tax of $3.8 billion/year'The report explained how two Pfizer subsidiaries in Singapore, a tax haven, earned a profit of $2.1 million in 2014 on revenues of $4.3 bil...
- Pfizer rallies over 6% on acquisition plans; scales above Rs 2000As per the report, Pfizer offered $90 per share in cash, a 39 percent premium to Hospira's closing stock price on Wednesday
- Pfizer paid no tax in UK despite £1.8b turnoverPfizer did not pay any corporation tax in the UK last year, despite having a whopping turnover of around £1.8 billion on its sales.
- Biocon's corporate governance standards raise alarm among analystsResearch firm ESPIROTO SANTO Investment bank has questioned the accounting practise of Bangalore based biotechnology company Biocon.
- Biocon logs smart recovery in fourth quarterAfter the divestment of Axicorp and the snapping of its biosimilar insulin deal with Pfizer, the company was expected to post a subdued per...
- Ranbaxy launches low-cost version of medicine 'Lipitor'The US FDA allowed Ranbaxy to make and sell atorvastatin tablets, the chemical name of Lipitor, ending months of uncertainty.
- Pfizer 4Q profit beats views as revenue up 6 pcPfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...
- Pfizer’s growth outlook seen strongThe Pfizer stock has offered better returns to investors than the Bombay Stock Exchange’s (BSE) benchmark index, the Sensex, over the past ...
- Pfizer profit dips 2 percent, sales fall much morePfizer Inc posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big dr...
- Pfizer Q3 profit doubles to $3.4bnPfizer on Thursday said third-quarter earnings doubled from the year-ago quarter when it took a big merger-related charge, helped by strong...
Load More
